name:-0.1394681930542
name:-0.070255994796753
name:-0.11199402809143
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Patent Filings

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Chia Tai Tianqing Pharmaceutical Group Co., Ltd..The latest application filed is for "fusion protein targeting pd-l1 and tgf- and use thereof".

Company Profile
131.147.151
  • Chia Tai Tianqing Pharmaceutical Group Co., Ltd. - Lianyungang, Jiangsu Province CN
  • CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. - Lianyungang CN
  • CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. - Jiangsu CN
  • CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. - Lianyungang, Jiangsu CN
  • CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. - Lianyungang City, Jiangsu CN
  • Chia Tai Tianqing Pharmaceutical Group Co., Ltd. - Lianyungang City CN
  • CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. - Lianyungang City, Jiangsu Province CN
  • CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD - Lianyungang, Jiangsu CN
  • CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. - Liangsu CN
  • CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. - Jiangsu, Lianyungang N/A CN
  • CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. - Jiangsu Province N/A CN
  • Chia Tai Tianqing Pharmaceutical Group Co., Ltd. - Beijing CN
  • CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. - Lianyunggang City CN
  • CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. - Liangsu, Lianyungang CN
  • Chia Tai Tianqing Pharmaceutical Group Co., Ltd. - Haizhou District N/A CN
  • CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD - Lianyungang City, Jiangsu CN
  • CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD - JIANGSU CN
  • CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD - Lianyungang N/A CN
  • CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD - Lianyungang, Xinpu District, Jiangsu CN
  • Chia Tai Tianqing Pharmaceutical Group Co., Ltd - Jiangsu Province CN
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Fusion Protein Targeting Pd-l1 And Tgf- And Use Thereof
App 20220289825 - ZHAO; Wei ;   et al.
2022-09-15
Bicyclic compound as a caspase inhibitor
Grant 11,434,212 - Mou , et al. September 6, 2
2022-09-06
Quinoline derivative for treatment of nasopharyngeal carcinoma
Grant 11,419,862 - Wang , et al. August 23, 2
2022-08-23
Toll-like Receptor Agonists For Use In The Treatment Of Hepatitis B
App 20220249488 - VAN REMOORTERE; Peter Jozef M ;   et al.
2022-08-11
Tlr7 Agonist For Treating Colorectal Cancer And Pharmaceutical Combination Thereof
App 20220235053 - XU; Hongjiang ;   et al.
2022-07-28
Tetracyclic Compounds As Cdc7 Inhibitors
App 20220235068 - Li; Gang ;   et al.
2022-07-28
Sulfonyl substituted bicyclic compound which acts as ROR inhibitor
Grant 11,396,503 - Wang , et al. July 26, 2
2022-07-26
Aryl-phosphorus-oxygen compound as EGFR kinase inhibitor
Grant 11,390,625 - Wu , et al. July 19, 2
2022-07-19
Methyl- And Trifluoromethyl-containing Disubstituted Sulfonamide Selective Bcl-2 Inhibitor
App 20220220110 - LIU; Fei ;   et al.
2022-07-14
Quinoline Derivatives For Treatment Of Head And Neck Cancer
App 20220211694 - WANG; Shanchun ;   et al.
2022-07-07
Quinoline Derivative Used For Soft Tissue Sarcoma Combination Therapy
App 20220211693 - WANG; Zhiming ;   et al.
2022-07-07
2,3-dihydro-1h-pyrrolizine-7-formamide Derivative And Application Thereof
App 20220204510 - HE; Haiying ;   et al.
2022-06-30
Quinoline Compound Or Pharmaceutically Acceptable Salt Thereof For Treating Ewing's Sarcoma
App 20220193067 - ZHAN; Xiaole ;   et al.
2022-06-23
Quinoline Derivative Used For Combination Treatment Of Small Cell Lung Cancer
App 20220193066 - WANG; Dong ;   et al.
2022-06-23
Solid Pharmaceutical Composition Comprising Tlr7 Agonist
App 20220184085 - Jing; Jianghui ;   et al.
2022-06-16
N-heterocyclic Five-membered Ring-containing Capsid Protein Assembly Inhibitor, Pharmaceutical Composition And Uses Thereof
App 20220185774 - ZHANG; Yinsheng ;   et al.
2022-06-16
SMAC mimetics used as IAP inhibitors and use thereof
Grant 11,358,950 - Liu , et al. June 14, 2
2022-06-14
Crystallization Of Smac Mimic Used As Iap Inhibitor And Preparation Method Thereof
App 20220177453 - Liu; Yingchun ;   et al.
2022-06-09
Combination Of Iap Inhibitor And Immune Checkpoint Inhibitor
App 20220175917 - LIU; Yingchun ;   et al.
2022-06-09
Combined Pharmaceutical Composition For Treating Small Cell Lung Cancer
App 20220175759 - WANG; Shanchun ;   et al.
2022-06-09
Therapeutic Combination Of Quinoline Derivative And Antibody
App 20220160700 - TIAN; Xin ;   et al.
2022-05-26
Diarylthiohydantoin compound as androgen receptor antagonist
Grant 11,332,465 - Shen , et al. May 17, 2
2022-05-17
Indolo Heptamyl Oxime Analogue As Parp Inhibitor
App 20220144850 - Hu; Yanbin ;   et al.
2022-05-12
Tricyclic Compounds Acting On Crbn Proteins
App 20220119376 - Lei; Maoyi ;   et al.
2022-04-21
Salt Of Egfr Inhibitor, Crystal Form, And Preparation Method Therefor
App 20220119431 - WU; Lingyun ;   et al.
2022-04-21
Crystals of glycyrrhizic acid derivatives, crystalline compositions, pharmaceutical compositions and uses thereof
Grant 11,292,809 - Zhou , et al. April 5, 2
2022-04-05
Crystals Of Quinolone Derivatives
App 20220098172 - ZHANG; Xiquan ;   et al.
2022-03-31
Combined Pharmaceutical Composition For Treating Tumor
App 20220089742 - ZHANG; Xiquan ;   et al.
2022-03-24
Crystalline of compound as c-Met kinase inhibitor and preparation method therefor and use thereof
Grant 11,279,676 - Gong , et al. March 22, 2
2022-03-22
Crystalline sulfamide compound
Grant 11,254,665 - Zhang , et al. February 22, 2
2022-02-22
Furo[3,4-b]pyrrole-containing Btk Inhibitor
App 20220033419 - Zhang; Yinsheng ;   et al.
2022-02-03
Quinoline Derivative Used For Treating Small Cell Lung Cancer
App 20220031689 - WANG; Shanchun ;   et al.
2022-02-03
Estrogen Receptor Antagonist
App 20220033376 - DUAN; Shuwen ;   et al.
2022-02-03
Crystal of tricyclic compound
Grant 11,236,107 - Liu , et al. February 1, 2
2022-02-01
Salt Of Syk Inhibitor And Crystalline Form Thereof
App 20220017498 - QIAN; Wenyuan ;   et al.
2022-01-20
Crystal Of Diarylthiohydantoin Compound
App 20220009925 - SHEN; Chunli ;   et al.
2022-01-13
Trifluoromethyl-substituted Sulfonamide As Bcl-2-selective Inhibitor
App 20220002290 - Liu; Fei ;   et al.
2022-01-06
Tricyclic Compund As Crth2 Inhibitor
App 20210403466 - CHEN; Bin ;   et al.
2021-12-30
Iridinesulfonamide compound and use method thereof
Grant 11,203,586 - Zhu , et al. December 21, 2
2021-12-21
Smac Mimetics Used As Iap Inhibitors And Use Thereof
App 20210371400 - Liu; Yingchun ;   et al.
2021-12-02
Tlr8 Agonist
App 20210371414 - Cai; Zhe ;   et al.
2021-12-02
Tlr8 Agonist
App 20210340141 - SUN; Fei ;   et al.
2021-11-04
Bicyclic Compound as a Caspase Inhibitor
App 20210332019 - MOU; Jianfeng ;   et al.
2021-10-28
Fused Tri-cyclic Compound As Pde3/pde4 Dual Inhibitor
App 20210323960 - LUO; Yunfu ;   et al.
2021-10-21
Crystals of Glycyrrhizic Acid Derivatives, Crystalline Compositions, Pharmaceutical Compositions and Uses Thereof
App 20210317155 - ZHOU; Zhou ;   et al.
2021-10-14
Sulfoximine Compound As Bromodomain Protein Inhibitor And Pharmaceutical Composition And Medical Use Thereof
App 20210300923 - LI; Jijun ;   et al.
2021-09-30
Method For Preparing Trifluridine
App 20210292356 - LIU; Lin ;   et al.
2021-09-23
Solid Pharmaceutical Composition Containing 1,3,5-triazine Derivative Or Salt Thereof
App 20210275534 - SUN; Yuanyuan ;   et al.
2021-09-09
Crystal Habit Of Quinoline Derivative And Preparation Method For Crystalline Powder Thereof
App 20210276973 - DONG; Ping ;   et al.
2021-09-09
Sultam compound and application method thereof
Grant 11,111,240 - Zhu , et al. September 7, 2
2021-09-07
Method for preparing cholic acid compound
Grant 11,111,265 - Zhang , et al. September 7, 2
2021-09-07
Isothiazolo[5,4-d]pyrimidine Compound As Irak4 Inhibitor
App 20210269459 - ZHANG; Yang ;   et al.
2021-09-02
Macrocycle containing aminopyrazole and pyrimidine and pharmaceutical composition and use thereof
Grant 11,098,060 - Dai , et al. August 24, 2
2021-08-24
Crystal of a caspase inhibitor
Grant 11,091,450 - Wu , et al. August 17, 2
2021-08-17
Syk inhibitor and use method therefor
Grant 11,091,460 - Liu , et al. August 17, 2
2021-08-17
1,3,5-triazine Derivative Salt, Crystal, Preparation Method, Pharmaceutical Composition And Use Thereof
App 20210246119 - Huang; Ticong ;   et al.
2021-08-12
Tlr7 Agonist And Pharmaceutical Combination Thereof For Treating Lung Cancer
App 20210220362 - Zhang; Xiquan ;   et al.
2021-07-22
Crystalline or amorphous form of steroid derivative FXR agonist, preparation method therefor and use thereof
Grant 11,059,853 - Li , et al. July 13, 2
2021-07-13
Method for preparing steroid derivative FXR agonist
Grant 11,059,854 - Li , et al. July 13, 2
2021-07-13
Crystal form of indole derivative and preparation method and use thereof
Grant 11,034,681 - Yao , et al. June 15, 2
2021-06-15
Borate Of Azetidine Derivative
App 20210163507 - Xiong; Jian ;   et al.
2021-06-03
Crystalline forms of 4-(tert-butoxyamino)-6-(6-(trifluoromethyl)pyridin-2-yl)-N-(2-(trifluorom- ethyl)pyridin-4-yl)-1,3,5-triazin-2-amine methanesulfonic acid salt
Grant 11,021,464 - Huang , et al. June 1, 2
2021-06-01
Iridinesulfonamide Compound And Use Method Thereof
App 20210155610 - ZHU; Li ;   et al.
2021-05-27
Azetidine derivative
Grant 11,014,943 - Xiong , et al. May 25, 2
2021-05-25
Caspase inhibitor and pharmaceutical composition, use and therapeutic method thereof
Grant 10,981,860 - He , et al. April 20, 2
2021-04-20
Crystal form A of 2-butoxy-7-(4-(pyrrolidin-1-ylmethyl)benzyl)-5H-pyrrolo[3,2-d]pyrimidin-4- -amine for inhibiting toll-like receptor activity
Grant 10,947,245 - Ding , et al. March 16, 2
2021-03-16
Inhaler
Grant D912,800 - Li , et al. March 9, 2
2021-03-09
Sultam Compound And Application Method Thereof
App 20210047314 - ZHU; Li ;   et al.
2021-02-18
Crystalline Of Compound As C-met Kinase Inhibitor And Preparation Method Therefor And Use Thereof
App 20210047272 - GONG; Feng ;   et al.
2021-02-18
Steroid Derivative FXR Agonist
App 20210040140 - HE; Haiying ;   et al.
2021-02-11
N-heterocyclic Five-membered Ring-containing Capsid Protein Assembly Inhibitor, Pharmaceutical Composition Thereof, And Use Thereof
App 20210017154 - ZHANG; Yinsheng ;   et al.
2021-01-21
Quinoline derivatives for non-small cell lung cancer
Grant 10,888,559 - Wang , et al. January 12, 2
2021-01-12
A Crystal Of A Caspase Inhibitor
App 20210002235 - Wu; Songliang ;   et al.
2021-01-07
Pharmaceutical composition comprising dabigatran etexilate, and preparation method, solid preparation and use thereof
Grant 10,881,615 - He , et al. January 5, 2
2021-01-05
Quinoline Derivative For Treatment Of Triple-negative Breast Cancer
App 20200405709 - TIAN; Xin ;   et al.
2020-12-31
Steroid derivative FXR agonist
Grant 10,875,888 - He , et al. December 29, 2
2020-12-29
Crystal of salt of quinazoline derivative
Grant 10,858,340 - Tang , et al. December 8, 2
2020-12-08
Anti-hbvtetrahydroisoxazolo[4,3-c]pyridine Compounds
App 20200377517 - WU; Lifang ;   et al.
2020-12-03
M-dihydroxybenzene derivative crystal and salt, and manufacturing method thereof
Grant 10,851,071 - Yan , et al. December 1, 2
2020-12-01
Tlr7 Agonist Maleate Salt, Crystalline Forms C, D And E Thereof, Preparation Methods And Uses Of Maleate Salt And Crystalline Forms
App 20200368241 - DING; Zhaozhong ;   et al.
2020-11-26
Inhaled Preparation Of Isoglycyrrhizic Acid Or Salt Thereof, And Use In Preparing Drugs For Treating Respiratory System Diseases
App 20200368158 - GU; Hongmei ;   et al.
2020-11-26
New dry powder inhaler
App 20200360631 - LI; Changhui ;   et al.
2020-11-19
Crystals Of Aniline Pyrimidine Compound Serving As Egfr Inhibitor
App 20200361908 - ZHU; Yizhong ;   et al.
2020-11-19
Quinoline Derivative For Treatment Of Nasopharyngeal Carcinoma
App 20200352932 - WANG; Shanchun ;   et al.
2020-11-12
Amino pyrazolopyrimidine compound used as neurotrophic factor tyrosine kinase receptor inhibitor
Grant 10,829,492 - Zhu , et al. November 10, 2
2020-11-10
Crystal Form Of Indole Derivative And Preparation Method And Use Thereof
App 20200347040 - Yao; Yuanshan ;   et al.
2020-11-05
Method For Preparing Cholic Acid Compound
App 20200347091 - ZHANG; Xiquan ;   et al.
2020-11-05
Crystal of DPP-IV long-acting inhibitor and salt
Grant 10,822,319 - Sang , et al. November 3, 2
2020-11-03
Method For Preparing Liposome
App 20200338519 - Zhang; Xiquan ;   et al.
2020-10-29
Indole derivative used as CRTH2 inhibitor
Grant 10,800,765 - Yao , et al. October 13, 2
2020-10-13
Application Of Novel Tyrosine Kinase Inhibitor, Anlotinib, In Osteosarcoma And Chondrosarcoma
App 20200316053 - HUA; Yingqi ;   et al.
2020-10-08
TLR7 agonist maleate salt, crystalline forms C, D and E thereof, preparation methods and uses of maleate salt and crystalline forms
Grant 10,780,091 - Ding , et al. Sept
2020-09-22
Macrocycle Containing Aminopyrazole And Pyrimidine And Pharmaceutical Composition And Use Thereof
App 20200291042 - DAI; Liguang ;   et al.
2020-09-17
Crystalline Sulfamide Compound
App 20200291012 - ZHANG; Xiquan ;   et al.
2020-09-17
Preparation method for chiral pyrrolopyrimidine compound
Grant 10,766,901 - Zhang , et al. Sep
2020-09-08
Silicon-containing compound for resistance to hepatitis C virus infection
Grant 10,766,912 - Zhang , et al. Sep
2020-09-08
Diarylthiohydantoin Compound As Androgen Receptor Antagonist
App 20200277290 - SHEN; Chunli ;   et al.
2020-09-03
1,3,5-triazine derivative and method of using same
Grant 10,745,383 - Zhao , et al. A
2020-08-18
Crystal Of Tricyclic Compound
App 20200255449 - Kind Code
2020-08-13
Quinoline derivative for treating gastric cancer
Grant 10,736,887 - Chen , et al. A
2020-08-11
Pharmaceutical Composition of Humanized Monoclonal Anti-PD-L1 Antibody
App 20200237906A1 -
2020-07-30
Sulfonyl Substituted Bicyclic Compound Which Acts As Ror Inhibitor
App 20200239454 - WANG; Xiaolong ;   et al.
2020-07-30
Method For Preparing Pyrrolo[3,2,-d]pyrimidine Compound, And Intermediates Thereof
App 20200239484 - DING; Zhaozhong ;   et al.
2020-07-30
Crystalline Or Amorphous Form Of Steroid Derivative Fxr Agonist, Preparation Method Therefor And Use Thereof
App 20200231621 - Li; Xiaolin ;   et al.
2020-07-23
Method For Preparing Steroid Derivative Fxr Agonist
App 20200231622 - Li; Xiaolin ;   et al.
2020-07-23
Bicylic Compound Acting As An Inhibitor
App 20200231597 - CHEN; Kevin X ;   et al.
2020-07-23
Deuterium-modified brigatinib derivatives, pharmaceutical compositions comprising same, and use thereof
Grant 10,717,753 - Zhang , et al.
2020-07-21
Aryl-Phosphorus-Oxygen Compound As EGFR Kinase Inhibitor
App 20200207768 - WU; Lingyun ;   et al.
2020-07-02
Inhaler
Grant D888,931 - Li , et al.
2020-06-30
Syk Inhibitor And Use Method Therefor
App 20200199101 - LIU; Shilan ;   et al.
2020-06-25
TLR7 agonist trifluoroacetate salt and crystalline form B thereof, preparation methods and uses
Grant 10,683,296 - Ding , et al.
2020-06-16
7-(thiazol-5-yl) pyrrolopyrimidine compound as TLR7 agonist
Grant 10,676,478 - Ding , et al.
2020-06-09
Method for preparing pyrrolo[3,2-D]pyrimidine compound, and intermediates thereof
Grant 10,654,856 - Ding , et al.
2020-05-19
1,3,5-triazine derivative and method of using same
Grant 10654826 -
2020-05-19
Crystal form, salt type of substituted 2-hydro-pyrazole derivative and preparation method therefor
Grant 10,626,107 - Ding , et al.
2020-04-21
Pyrrolopyrimidine crystal for preparing JAK inhibitor
Grant 10,626,118 - Zhou , et al.
2020-04-21
Azetidine Derivative
App 20200115392 - XIONG; Jian ;   et al.
2020-04-16
Pyrrolopyrimidine comprising cyclopentyl substituent
Grant 10,617,692 - Zhu , et al.
2020-04-14
Substituted pyrrolopyrimidine CDK inhibitor, pharmaceutical composition containing same and use thereof
Grant 10,570,141 - Wang , et al. Feb
2020-02-25
Pyrrolopyrimidine compound
Grant 10,561,657 - Zhu , et al. Feb
2020-02-18
Synthesis process of ruxolitinib
Grant 10,562,904 - Zhang , et al. Feb
2020-02-18
Use of quinoline derivatives for treating oesophageal cancer and treatment method, pharmaceutical composition and kit thereof
Grant 10,561,647 - Wang , et al. Feb
2020-02-18
Pyrrolopyrimidine compounds used as TLR7 agonist
Grant 10,555,949 - Ding , et al. Feb
2020-02-11
Tlr7 Agonist Crystalline Form A, Preparation Method And Use Thereof
App 20200039988 - DING; Zhaozhong ;   et al.
2020-02-06
Silicon-containing Compound For Resistance To Hepatitis C Virus Infection
App 20200017532 - ZHANG; Yinsheng ;   et al.
2020-01-16
Steroid Derivative FXR Agonist
App 20190382437 - HE; Haiying ;   et al.
2019-12-19
Method for preparing intermediate of 6-arylaminopyridonecarboxamide compound as MEK inhibitor
Grant 10,501,468 - Wang , et al. Dec
2019-12-10
Tricyclic compound serving as immunomodulator
Grant 10,487,088 - Liu , et al. Nov
2019-11-26
Amino Pyrazolopyrimidine Compound Used As Neurotrophic Factor Tyrosine Kinase Receptor Inhibitor
App 20190352306 - ZHU; Li ;   et al.
2019-11-21
1,3,5-triazine Derivative Salt, Crystal, Preparation Method, Pharmaceutical Composition And Use Thereof
App 20190352281 - Huang; Ticong ;   et al.
2019-11-21
Pyrido[1,2-A]pyrimidone analog, crystal form thereof, intermediate thereof and preparation method therefor
Grant 10,479,789 - Yu , et al. Nov
2019-11-19
Pyrrolopyrimidine Crystal For Preparing Jak Inhibitor
App 20190330215 - Zhou; Zhou ;   et al.
2019-10-31
Crystals of thiadiazole derivative DPP-IV inhibitors and uses thereof
Grant 10,450,328 - Peng , et al. Oc
2019-10-22
Crystal form A of 2-butoxy-7-(4-(pyrrolidin-1-ylmethyl)benzyl)-5H-pyrrolo[3,2-D] pyrimidin-4-amine, preparation process and use thereof
Grant 10,442,811 - Ding , et al. Oc
2019-10-15
Quinoline Derivatives For Non - Small Cell Lung Cancer
App 20190298712 - Wang; Xunqiang ;   et al.
2019-10-03
Substituted Pyrrolopyrimidine Cdk Inhibitor, Pharmaceutical Composition Containing Same And Use Thereof
App 20190300533 - Wang; Shulong ;   et al.
2019-10-03
Crystal Of Dpp-iv Long-acting Inhibitor And Salt
App 20190284153 - Sang; Guangming ;   et al.
2019-09-19
M-dihydroxybenzene Derivative Crystal And Salt, And Manufacturing Method Thereof
App 20190284146 - YAN; Xiaobing ;   et al.
2019-09-19
Method For Treating Tumour, Pharmaceutical Composition And Medicinal Kit
App 20190269671 - Wang; Shanchun ;   et al.
2019-09-05
Crystals Of Aniline Pyrimidine Compound Serving As Egfr Inhibitor
App 20190256497 - ZHU; YIZHONG ;   et al.
2019-08-22
Pyridine substituted 2-aminopyridine protein kinase inhibitor crystal
Grant 10,385,038 - Gong , et al. A
2019-08-20
Indole Derivative Used As Crth2 Inhibitor
App 20190248770 - YAO; Yuanshan ;   et al.
2019-08-15
Crystal of aniline pyrimidine compound of trifluoroethyl substituted indole and salt thereof
Grant 10,376,512 - Wang , et al. A
2019-08-13
Pharmaceutical composition of MEK inhibitor and preparation method thereof
Grant 10,350,198 - He , et al. July 16, 2
2019-07-16
Preparation Method For Chiral Pyrrolopyrimidine Compound
App 20190211021 - ZHANG; Xiquan ;   et al.
2019-07-11
Pyrrolopyrimidine Compound
App 20190201403 - Zhu; Li ;   et al.
2019-07-04
Crystal Form, Salt Type Of Substituted 2-hydro-pyrazole Derivative And Preparation Method Therefor
App 20190194168 - Ding; Charles Z. ;   et al.
2019-06-27
N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(3-methyl-2-O- XO-2,3-dihydro-1h-benzo[d]imidazol-1-yl)pyrimidin-2-yl)amino)phenyl)acryla- mide hydrochloride as an inhibitor of epidermal growth factor receptor activity
Grant 10,329,277 - Zhu , et al.
2019-06-25
Pyrrolopyrimidine Comprising Cyclopentyl Substituent
App 20190183899 - ZHU; Li ;   et al.
2019-06-20
Crystal Of Salt Of Quinazoline Derivative
App 20190185453 - TANG; Song ;   et al.
2019-06-20
Method For Preparing Intermediate Of 6-arylaminopyridonecarboxamide Compound As Mek Inhibitor
App 20190177335 - Wang; Lulu ;   et al.
2019-06-13
Quinoline derivative against non-small cell lung cancer
Grant 10,307,412 - Wang , et al.
2019-06-04
Nintedanib diethanesulfonate salt crystal and preparation method and use thereof
Grant 10,292,965 - Wang , et al.
2019-05-21
Caspase Inhibitor And Pharmaceutical Composition, Use And Therapeutic Method Thereof
App 20190135733 - He; Haiying ;   et al.
2019-05-09
Quinoline Derivative For Treating Gastric Cancer
App 20190125739 - Chen; Jie ;   et al.
2019-05-02
Inhaled Preparation Of Isoglycyrrhizic Acid Or Salt Thereof, And Use In Preparing Drugs For Treating Respiratory System Diseases
App 20190117568 - GU; Hongmei ;   et al.
2019-04-25
Method for treating tumour, pharmaceutical composition and medicinal kit
Grant 10,251,876 - Wang , et al.
2019-04-09
Salts of quinazoline derivative and method for preparing the same
Grant 10,231,973 - Zhang , et al.
2019-03-19
Tlr7 Agonist Maleate Salt, Crystalline Forms C, D And E Thereof, Preparation Methods And Uses Of Maleate Salt And Crystalline Forms
App 20190070179 - DING; Zhaozhong ;   et al.
2019-03-07
Deuterium-substituted Quinoline Derivatives
App 20190062307 - ZHANG; Yinsheng ;   et al.
2019-02-28
1,3,5-triazine Derivative And Method Of Using Same
App 20190062308 - ZHAO; Na ;   et al.
2019-02-28
Tricyclic Compound Serving As Immunomodulator
App 20190062338 - Liu; Shilan ;   et al.
2019-02-28
Process for preparing ibrutinib
Grant 10,214,532 - Zhang , et al. Feb
2019-02-26
Tricyclic Compound For Bromodomain-containing Protein Inhibitor And Preparation Pharmaceutical Composition, And Application Thereof
App 20190040063 - LI; Jijun ;   et al.
2019-02-07
Tlr7 Agonist Crystalline Form A, Preparation Method And Use Thereof
App 20190040071 - DING; Zhaozhong ;   et al.
2019-02-07
Method For Preparing Pyrrolo[3,2-d]pyrimidine Compound, And Intermediates Thereof
App 20190040072 - DING; Zhaozhong ;   et al.
2019-02-07
Tlr7 Agonist Trifluoroacetate Salt And Crystalline Form B Thereof, Preparation Methods And Uses
App 20190031666 - DING; Zhaozhong ;   et al.
2019-01-31
Use Of Quinoline Derivatives For Treating Oesophageal Cancer And Treatment Method, Pharmaceutical Composition And Kit Thereof
App 20190022082 - WANG; Xunqiang ;   et al.
2019-01-24
Synthesis Process Of Ruxolitinib
App 20190023712 - Zhang; Xiquan ;   et al.
2019-01-24
Methods and uses of quinoline derivatives in the treatment of soft tissue sarcomas and pharmaceutical compositions for treatment of same
Grant 10,183,017 - Zhang , et al. Ja
2019-01-22
7-(thiazol-5-yl) Pyrrolopyrimidine Compound As Tlr7 Agonist
App 20180370976 - DING; Zhaozhong ;   et al.
2018-12-27
Sorafenib Hemi-p-tosylate Monohydrate Crystal And Preparation Process Thereof
App 20180370918 - WU; Shufeng ;   et al.
2018-12-27
Method for Preparing Liposome
App 20180361342 - ZHANG; Xiquan ;   et al.
2018-12-20
Substituted amino six-membered saturated heteroalicycles as long-acting DPP-IV inhibitors
Grant 10,155,775 - Xu , et al. Dec
2018-12-18
Antitumor compound targeting IDH2 mutation and method of use thereof
Grant 10,155,722 - Wang , et al. Dec
2018-12-18
Kinase Activity Regulating Compound Intermediates Preparation Method
App 20180346418 - LI; Jijun ;   et al.
2018-12-06
Deuterium-Modified Brigatinib Derivatives, Pharmaceutical Compositions Comprising Same, And Use Thereof
App 20180346498 - ZHANG; Yinsheng ;   et al.
2018-12-06
Crystals Of Thiadiazole Derivative Dpp-iv Inhibitors And Uses Thereof
App 20180334466 - Peng; Yan ;   et al.
2018-11-22
Pyrido[1,2-a]pyrimidone Analog, Crystal Form Thereof, Intermediate Thereof And Preparation Method Therefor
App 20180319799 - Yu; Tao ;   et al.
2018-11-08
Method for preparing dabigatran etexilate intermediate, and intermediate compound
Grant 10,112,901 - Guo , et al. October 30, 2
2018-10-30
Pyrrolopyrimidine Compounds Used As Tlr7 Agonist
App 20180303832 - DING; Zhaozhong ;   et al.
2018-10-25
Pyridine Substituted 2-aminopyridine Protein Kinase Inhibitor Crystal
App 20180244649 - GONG; Feng ;   et al.
2018-08-30
Methods And Uses Of Quinoline Derivatives In The Treatment Of Soft Tissue Sarcomas And Pharmaceutical Compositions For Treatment Of Same
App 20180235953 - Zhang; Xiquan ;   et al.
2018-08-23
Antitumor Compound Targeting Idh2 Mutation And Method Of Use Thereof
App 20180222853 - WANG; Shulong ;   et al.
2018-08-09
Resorcinol derivative as HSP90 inhibitor
Grant 10,035,792 - Chen , et al. July 31, 2
2018-07-31
Aniline Pyrimidine Derivatives And Uses Thereof
App 20180208581 - ZHU; Yan ;   et al.
2018-07-26
6-aryl amino pyridone formamide compound crystal and preparation method therefor
Grant 10,023,582 - Wang , et al. July 17, 2
2018-07-17
Pyridine-substituted 2-aminopyridine protein kinase inhibitors
Grant 9,981,946 - Gong , et al. May 29, 2
2018-05-29
Methods and uses of quinoline derivatives in the treatment of soft tissue sarcomas and pharmaceutical compositions for treatment of same
Grant 9,968,597 - Zhang , et al. May 15, 2
2018-05-15
Substituted 2-hydrogen-pyrazole derivative serving as anticancer drug
Grant 9,969,719 - Ding , et al. May 15, 2
2018-05-15
Pyrrolopyrimidine compounds used as TLR7 agonist
Grant 9,962,388 - Ding , et al. May 8, 2
2018-05-08
Substituted Amino Six-membered Saturated Heteroalicycles As Long-acting Dpp-iv Inhibitors
App 20180111950 - XU; Xinhe ;   et al.
2018-04-26
Salts Of Quinazoline Derivative And Method For Preparing The Same
App 20180085369 - ZHANG; Xiquan ;   et al.
2018-03-29
Substituted 2-hydrogen-pyrazole Derivative Serving As Anticancer Drug
App 20180072707 - Ding; Charles Z. ;   et al.
2018-03-15
Nintedanib Diethanesulfonate Salt Crystal And Preparation Method And Use Thereof
App 20180064684 - Wang; Hubo ;   et al.
2018-03-08
Process For Preparing Ibrutinib
App 20180044339 - ZHANG; Xiquan ;   et al.
2018-02-15
Resorcinol Derivative As HSP90 Inhibitor
App 20180009794 - CHEN; Shuhui ;   et al.
2018-01-11
Pyridino[1,2-A]pyrimidone analogue used as P13K inhibitor
Grant 9,856,256 - Wu , et al. January 2, 2
2018-01-02
Pharmaceutical Composition Comprising Dabigatran Etexilate, And Preparation Method, Solid Preparation And Use Thereof
App 20170333350 - He; Xiongxiong ;   et al.
2017-11-23
Quinoline Derivative Against Non-small Cell Lung Cancer
App 20170304290 - Wang; Xunqiang ;   et al.
2017-10-26
Pyrrolopyrimidine Compounds Used As Tlr7 Agonist
App 20170273983 - DING; Zhaozhong ;   et al.
2017-09-28
Pyridine-substituted 2-aminopyridine Protein Kinase Inhibitors
App 20170226084 - GONG; Feng ;   et al.
2017-08-10
Quinazoline derivative and preparation method therefor
Grant 9,725,439 - Xiao , et al. August 8, 2
2017-08-08
6-aryl Amino Pyridone Formamide Compound Crystal And Preparation Method Therefor
App 20170217979 - WANG; LULU ;   et al.
2017-08-03
Substituted 2-aminopyridine protein kinase inhibitor
Grant 9,708,295 - Xiao , et al. July 18, 2
2017-07-18
Method For Preparing Dabigatran Etexilate Intermediate, And Intermediate Compound
App 20170190666 - GUO; Yajun ;   et al.
2017-07-06
Method For Treating Tumour, Pharmaceutical Composition And Medicinal Kit
App 20170182027 - Wang; Shanchun
2017-06-29
Pyridino[1,2-a]pyrimidone Analogue Used As P13k Inhibitor
App 20170137420 - WU; Chengde ;   et al.
2017-05-18
Kinase modulating compounds, compositions containing the same and use thereof
Grant 9,550,781 - Xiao , et al. January 24, 2
2017-01-24
6-arylamino pyridone carboxamide as MEK inhibitors
Grant 9,540,396 - Xiao , et al. January 10, 2
2017-01-10
Quinazoline Derivative And Preparation Method Therefor
App 20160214964 - XIAO; Dengming ;   et al.
2016-07-28
Substituted 2-aminopyridine Protein Kinase Inhibitor
App 20160002205 - Xiao; Dengming ;   et al.
2016-01-07
Trolox derivative-modified fat-soluble anti-cancer pharmaceutical compounds, preparations, preparing methods and use thereof
Grant 9,206,192 - Zhang December 8, 2
2015-12-08
Trolox Derivative-modified Fat-soluble Anti-cancer Pharmaceutical Compounds, Preparations, Preparing Methods And Use Thereof
App 20140343088 - Zhang; Yuehua
2014-11-20
Kinase Modulating Compounds, Compositions Containing The Same And Use Thereof
App 20140296261 - Xiao; Dengming ;   et al.
2014-10-02
Crystals of prasugrel hydrobromate
Grant 8,772,488 - Yuan , et al. July 8, 2
2014-07-08
Lamivudine oxalate and preparation method thereof
Grant 8,569,322 - Liu , et al. October 29, 2
2013-10-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed